GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (WBO:PFE) » Definitions » Shiller PE Ratio

Pfizer (WBO:PFE) Shiller PE Ratio : 9.65 (As of Apr. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Pfizer Shiller PE Ratio?

As of today (2024-04-26), Pfizer's current share price is €23.845. Pfizer's E10 for the quarter that ended in Dec. 2023 was €2.47. Pfizer's Shiller PE Ratio for today is 9.65.

The historical rank and industry rank for Pfizer's Shiller PE Ratio or its related term are showing as below:

WBO:PFE' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.38   Med: 17.48   Max: 24.28
Current: 9.67

During the past years, Pfizer's highest Shiller PE Ratio was 24.28. The lowest was 9.38. And the median was 17.48.

WBO:PFE's Shiller PE Ratio is ranked better than
89.96% of 518 companies
in the Drug Manufacturers industry
Industry Median: 24.12 vs WBO:PFE: 9.67

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pfizer's adjusted earnings per share data for the three months ended in Dec. 2023 was €-0.550. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €2.47 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pfizer Shiller PE Ratio Historical Data

The historical data trend for Pfizer's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Shiller PE Ratio Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.89 17.21 23.38 17.14 10.60

Pfizer Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.14 13.21 12.63 11.69 10.60

Competitive Comparison of Pfizer's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Pfizer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Shiller PE Ratio falls into.



Pfizer Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pfizer's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=23.845/2.47
=9.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Pfizer's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.55/129.4194*129.4194
=-0.550

Current CPI (Dec. 2023) = 129.4194.

Pfizer Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.260 99.695 0.338
201406 0.331 100.560 0.426
201409 0.326 100.428 0.420
201412 0.154 99.070 0.201
201503 0.351 99.621 0.456
201506 0.374 100.684 0.481
201509 0.303 100.392 0.391
201512 -0.028 99.792 -0.036
201603 0.440 100.470 0.567
201606 0.294 101.688 0.374
201609 0.196 101.861 0.249
201612 0.123 101.863 0.156
201703 0.477 102.862 0.600
201706 0.454 103.349 0.569
201709 0.394 104.136 0.490
201712 1.707 104.011 2.124
201803 0.478 105.290 0.588
201806 0.556 106.317 0.677
201809 0.591 106.507 0.718
201812 -0.062 105.998 -0.076
201903 0.602 107.251 0.726
201906 0.788 108.070 0.944
201909 1.235 108.329 1.475
201912 -0.054 108.420 -0.064
202003 0.543 108.902 0.645
202006 0.551 108.767 0.656
202009 0.221 109.815 0.260
202012 0.082 109.897 0.097
202103 0.722 111.754 0.836
202106 0.813 114.631 0.918
202109 1.207 115.734 1.350
202112 0.522 117.630 0.574
202203 1.244 121.301 1.327
202206 1.637 125.017 1.695
202209 1.525 125.227 1.576
202212 0.821 125.222 0.849
202303 0.906 127.348 0.921
202306 0.378 128.729 0.380
202309 -0.394 129.860 -0.393
202312 -0.550 129.419 -0.550

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pfizer  (WBO:PFE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pfizer Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pfizer's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (WBO:PFE) Business Description

Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (WBO:PFE) Headlines

From GuruFocus

Pfizer Inc to Review Oral GLP-1 Data Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc's Dividend Analysis

By GuruFocus Research 01-24-2024

Pfizer Inc to Discuss Climate Action Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Citi BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc To Host Investment Analysts Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Wells Fargo Healthcare Conference Transcript

By GuruFocus Research 01-23-2024